A Phase 1/2 interventional study of Epidural Spinal Cord Stimulation System in Spinal Cord Injury, sponsored by University of Minnesota. Recruiting at 1 site in United States. Open to participants aged 22 Years and older. Per ClinicalTrials.gov, last updated 2026-03-27.
Sponsored by University of Minnesota · Phase 1/2, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in Spinal Cord Injuries by University of Minnesota — 7 open to participants now, 7 under way, none of them phase 3. Spinal Cord Injuries · University of Minnesota.
Among the 15 studies in Spinal Cord Injuries by University of Minnesota, this one is the 7th largest by planned enrollment of the 12 interventional ones that give a count, is one of 2 that started in 2026, is one of 2 in phase 1/2, and was the 13th registered.
2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.
Browse Spinal Cord Injuries studies →7 of the 15 studies in Spinal Cord Injuries by University of Minnesota are open now, in 1 country. Recruiting first, the newest first:
University of Minnesota · Sites in United States
Ages 18+ · Healthy volunteers
University of Minnesota · Sites in United States
Ages 18+
University of Minnesota · Sites in United States
Ages 22+
University of Minnesota · Sites in United States
Ages 22+
University of Minnesota · Sites in United States
Ages 22+
By country, each count listing its studies:
Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.
This study: 22 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 3 · Phase 3 1
First in 2015; this study’s year is marked. 2 started in 2026.
This study's planned enrollment of 36 is above the median of 24 across 1,639 interventional studies indexed under Spinal Cord Injuries.
Median enrollment 38 across the 12 interventional studies, 113 across the 3 observational. Of the 8 that completed or were terminated, 2 (25%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of Minnesota is the lead sponsor of 1,219 studies on the registry; 199 are open to participants now.
Of its 136 completed or terminated interventional studies of FDA-regulated products, 95 (70%) have results posted.
4 of the studies in Spinal Cord Injuries by University of Minnesota that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03026816University of MinnesotaEpidural Stimulation After Neurologic Damage | 2027-01 |
| NCT06140355University of MinnesotacHAnging the Perceived Pain INtensity in divErSe Populations With Spinal Cord Injury | 2027-01-31 |
| NCT07029802University of MinnesotaDevelopment of a Novel Evaluation Scale of Mental Body Representation (MBR) for Adults With Spinal Cord Injury | 2027-06-15 |
| NCT05741788University of MinnesotaThe Teaspoon Study - Telefitting Spinal Cord Stimulation for Pain | 2027-10-01 |
Add all 4 to your calendar (.ics) → With an account.
Among the 15 studies in Spinal Cord Injuries by University of Minnesota, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
CE-STAND aims to address three areas under-represented in research: chronic, cervical, and autonomic dysfunction. It is both significant and highly impactful, as treating autonomic dysfunction could substantially improve function and quality of life (QoL) in chronic cervical SCI patients.
Spinal cord injury (SCI) affects over 18,000 individuals annually, leading to significant motor and autonomic dysfunctions that reduce quality of life (QoL). Epidural spinal cord stimulation (eSCS) has shown potential in restoring function in chronic individuals with SCI. However, research on cervical, and autonomic dysfunction-related SCI remains limited. This study will assess the safety and efficacy of eSCS in improving autonomic and volitional functions, as well as truncal stability, bowel, bladder, and sexual function, and overall QoL.
The study is a Phase I/II trial in which participants will serve as their own controls. The Abbott Eterna epidural stimulator system will be implanted, and assessments will occur every three months. The study will be conducted over a period of four years. A total of 36 participants will be enrolled and followed for one year.
Bayesian Optimization will be used to determine the most effective stimulation settings, with 15 settings programmed at the end of each visit.
FDA and UMN IRB approvals have been secured for the study. Interim reports will be made available through peer-reviewed journals, conference presentations, and clinical network reporting.
CE-STAND seeks to advance SCI treatment by expanding eSCS applications in chronic cervical SCI, improving patient outcomes, and reducing healthcare costs.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Clinically significant
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Experimental: Individuals with cervical SCI comparing stimulation "on" vs "off" longitudinally.
Device: Epidural Spinal Cord Stimulation System
Abbott Eterna system implantable pulse generator (IPG), charger, and TriCentrus lead
Safety of epidural spinal cord stimulator in chronic cervical patients
Incidence of adverse events (AEs) and serious adverse events (SAEs) including hypotension, other hemodynamic instability, infection, bleeding, significant pain, spasticity, or cerebrospinal fluid leak.
Time frame: 1 year
Changes in blood pressure
Measured on tilt table testing. Both systolic and diastolic pressure will be assessed
Time frame: 1 year
Changes in heart rate
Measured on tilt table testing
Time frame: 1 year
Cognitive function
Measured using N-back testing
Time frame: 1 year
Cerebral blood flow
Measured using transcranial doppler
Time frame: 1 year
Muscle Sympathetic Nerve Activities (MSNA)
Microneurolography
Time frame: 1 year
Volitional function on electromyography (EMG)
Using the modified brain motor control assessment (mBMCA) and electromyography (EMG).
Time frame: 1 year
Hand function
The Graded Redefined Assessments of Strength, Sensibility, and Prehension (GRASSP) functional score
Time frame: 1 year
Truncal stability
Using the modified Functional reach test (mFRT)
Time frame: 1 year
Stimulation settings optimization
Using Bayesian process
Time frame: 1 year
Plan to share: Yes — De-identified data will be deposited in the Data Repository for the University of Minnesota (DRUM), an open-access institutional repository. Data stored during the project will be maintained in Box Secure Storage and REDCap before long-term archiving in DRUM.
Supporting information: Study protocol, Analytic code
Time frame: Data will be shared after publication of the primary results and will remain available for at least 10 years, in accordance with the University of Minnesota's DRUM repository policies.
Access criteria: Data will be openly accessible through DRUM without restrictions.
Data sharing details ↗ · hdl.handle.net
Started Mar 2026 (actual). Primary completion is estimated for May 2030, 50 months after the start.
Of 24 phase 1/2 interventional studies under Spinal Cord Injuries, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 24 and three quarters within 60. This study's planned 50 months is above that.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.